Migrén: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• CGRP 19
• HMGB1 0
• NOTCH3 0
• GLP-1 0
• MAPK 0
• PI3K 0
• IL-17 0
• IL-6 1
• TNF 1
• PPAR 0
• TREM2 0
• COX-2 0
• IL-4 0
• STING 0
• AKT 0
• AMPK 0
• AQP4 0
• ERK 0
• GIP 0
• GPX4 0
• HIF-1 0
• IL-1 1
• mTOR 0
• NLRP3 0
• NMDA 0
• PD-1 0
• SCN1A 0
• SCN2A 0
• STAT3 0
• VEGF 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-JU-IA

  closed-loop IMPlantable tHerapeutic neurOmodulation systems enabled by advanced micRoelectronics and Innovative pAckaging (IMPHORIA)

  Salvia Bioelectronics Bv· Eindhoven, Hollandia· EU contribution 4 567 844 EUR· until 2029. ápr.· 5 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-JU-RIA

  Hospital@Home: Person-centered Digital Transformation for Integrated Home Care (HospitalAtHome)

  Erasmus Universitair Medisch Centrum Rotterdam· Rotterdam, Hollandia· EU contribution 14 179 766 EUR· until 2030. dec.· 8 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Combinatorial use of cannabidiol and the serine hydrolase inhibitor AKU-005 to enhance endocannabinoids for treatment of migraine (Migraine cannabinoid)

  King's College London· London, Egyesült Királyság· EU contribution 454 103 EUR· until 2028. jún.· 2 countries

• European Commission (Horizon Europe) · HORIZON-EIC-ACC

  INNOVATIVE SOLUTION OF ELECTRO-FOCUS EYEGLASSES (I-SEE)

  Laclaree· Lyon, Franciaország· EU contribution 2 499 999 EUR· until 2026. nov.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  A mechanism-based approach to the prevention of chronic pain and its comorbid mental disorders (MECHPAIN)

  Zentralinstitut Fuer Seelische Gesundheit· Mannheim, Németország· EU contribution 2 424 481 EUR· until 2029. szept.

  The disease is named only in the funder's project summary, not in the title.

5 of 6 running projects, newest first. Listed amounts together: 26,6 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 7
• Mendelian Randomization Analysis 33
• Gene Expression Profiling 8
• Sequence Analysis, RNA 2
• Exome Sequencing 5
• Proteomics 6
• Metabolomics 6
• Mass Spectrometry 1
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 136
• Machine Learning 32
• Deep Learning 1
• Cohort Studies 82
• Genome-Wide Association Study 40

• Telomere length as a systemic aging-related susceptibility marker for trigeminal neuralgia: Genetic evidence from mendelian randomization.

  Mol Pain, 2026. nov.

• Integrative genetic analysis identifies shared regulation of DNA methylation and gene expression in migraine risk.

  J Headache Pain, 2026. júl.

• Migraine immune cell gene targets and their relationship to psychiatric disorders.

  J Headache Pain, 2026. júl.

• Genetic regulation of cell type-specific chromatin accessibility contributes to migraine etiology.

  J Headache Pain, 2026. júl.

• Migraine is not a risk factor for glaucoma: Evidence from a bidirectional Mendelian randomization study.

  Medicine (Baltimore), 2026. jún.

• Dissecting the shared genetic architecture between migraine subtypes and cardiovascular diseases: a multi-layered genomic analysis.

  J Headache Pain, 2026. jún.

• Machine Diagnostics and Machine Phenotyping of Migraine: A HUNT Study.

  Neurology, 2026. jún.

• Genome-wide analysis implicates inner ear development in Ménière disease.

  Am J Hum Genet, 2026. jún.

• A phenome-wide association study reveals novel phenotypic determinants of migraine risk in the UK Biobank.

  Headache, 2026. jún.

• Genome-wide meta-analysis of quantitatively measured generalized anxiety symptoms in individuals of European ancestry.

  Nat Hum Behav, 2026. jún.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.